CD163 and neoplasm: With regard to clinical parameters, we found an association between high CD163 expression and shorter survival, as well as between high CD163 and TIGIT levels and features of a more aggressive and invasive tumor growth, such as residual tumor after surgery, vascular and lymphovascular invasion in HGSOC patients.